Catalio Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001958125 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 14, 2025

Total Value: $457M (100.0% shares, 0.0% debt)

Holdings (33)

BDX BECTON DICKINSON & CO 7.4%
Value $33.72M Shares 148,615 Est. Cost $225.20 Unrealized 0.0%
ASND ASCENDIS PHARMA A/S 6.5%
Value $29.68M Shares 215,587 Est. Cost $137.67 Unrealized
BMY BRISTOL-MYERS SQUIBB CO 6.2%
Value $28.23M Shares 499,151 Est. Cost $52.58 Unrealized 0.0%
SPRINGWORKS THERAPEUTICS INC 6.0%
Value $27.63M Shares 764,668 Est. Cost $36.13 Unrealized
BLUEPRINT MEDICINES CORP 5.4%
Value $24.83M Shares 284,654 Est. Cost $87.22 Unrealized
EW EDWARDS LIFESCIENCES CORP 5.4%
Value $24.66M Shares 333,144 Est. Cost $69.99 Unrealized 0.0%
BBIO BRIDGEBIO PHARMA INC 5.4%
Value $24.65M Shares 898,458 Est. Cost $25.84 Unrealized 0.0%
LIVN LIVANOVA PLC 5.2%
Value $23.73M Shares 512,447 Est. Cost $51.28 Unrealized 0.0%
SEPN SEPTERNA INC 5.1%
Value $23.46M Shares 1,024,245 Est. Cost $23.65 Unrealized 0.0%
CYTK CYTOKINETICS INC 4.7%
Value $21.52M Shares 457,587 Est. Cost $51.94 Unrealized 0.0%
NVST ENVISTA HOLDINGS CORPORATION 4.3%
Value $19.67M Shares 1,019,529 Est. Cost $19.78 Unrealized 0.0%
VCYT VERACYTE INC 4.2%
Value $19.43M Shares 490,547 Est. Cost $37.86 Unrealized 0.0%
ISRG INTUITIVE SURGICAL INC 4.2%
Value $19.27M Shares 36,910 Est. Cost $520.85 Unrealized 0.0%
EXAS EXACT SCIENCES CORP 3.8%
Value $17.37M Shares 309,103 Est. Cost $62.23 Unrealized 0.0%
DNTH DIANTHUS THERAPEUTICS INC 3.6%
Value $16.64M Shares 763,471 Est. Cost $25.71 Unrealized 0.0%
QURE UNIQURE NV 3.5%
Value $15.93M Shares 901,973 Est. Cost $8.63 Unrealized 0.0%
GPCR STRUCTURE THERAPEUTICS INC 3.4%
Value $15.44M Shares 569,395 Est. Cost $27.12 Unrealized
MASI MASIMO CORP 3.2%
Value $14.44M Shares 87,377 Est. Cost $157.91 Unrealized 0.0%
IRON DISC MEDICINE INC 2.5%
Value $11.4M Shares 179,815 Est. Cost $57.84 Unrealized 0.0%
ADMA ADMA BIOLOGICS INC 1.9%
Value $8.793M Shares 512,724 Est. Cost $18.81 Unrealized 0.0%
INARI MED INC 1.5%
Value $6.766M Shares 132,545 Est. Cost $51.05 Unrealized
BSX BOSTON SCIENTIFIC CORP 1.4%
Value $6.514M Shares 72,925 Est. Cost $88.03 Unrealized 0.0%
KROS KEROS THERAPEUTICS INC 1.4%
Value $6.447M Shares 407,292 Est. Cost $51.97 Unrealized 0.0%
TARA PROTARA THERAPEUTICS INC 1.3%
Value $5.748M Shares 1,088,691 Est. Cost $3.23 Unrealized 0.0%
MERSANA THERAPEUTICS INC 0.5%
Value $2.438M Shares 1,705,036 Est. Cost $1.43 Unrealized
KYTX KYVERNA THERAPEUTICS INC 0.5%
Value $2.195M Shares 586,909 Est. Cost $4.79 Unrealized 0.0%
MGX METAGENOMI INC 0.4%
Value $1.91M Shares 528,993 Est. Cost $2.41 Unrealized 0.0%
KARYOPHARM THERAPEUTICS INC 0.3%
Value $1.579M Shares 2,334,375 Est. Cost $0.68 Unrealized
ZBIO ZENAS BIOPHARMA INC 0.3%
Value $1.533M Shares 187,184 Est. Cost $15.60 Unrealized 0.0%
HYPR HYPERFINE INC 0.1%
Value $669K Shares 760,035 Est. Cost $0.96 Unrealized 0.0%
GUTS FRACTYL HEALTH INC 0.1%
Value $441K Shares 214,236 Est. Cost $2.33 Unrealized 0.0%
ATAI LIFE SCIENCES NV 0.1%
Value $262K Shares 196,858 Est. Cost $1.33 Unrealized
SENSEI BIOTHERAPEUTICS INC 0.0%
Value $144K Shares 294,374 Est. Cost $0.49 Unrealized